Hunt Holdings Limited Partnership Insider Trades

Insider Trading History

Track insider trading activity for Hunt Holdings Limited Partnership. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Exagen
Exagen XGN
10% owner
Holding Value $6.04M 1,261,324 shares
Last Trade
Jan 25, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$449k 28,021 shares
$16.01
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $6.18M 1,289,345 shares
Last Trade
Jan 22, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$380k 23,646 shares
$16.07
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $6.29M 1,312,991 shares
Last Trade
Jan 21, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$801k 50,000 shares
$16.01
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $6.53M 1,362,991 shares
Last Trade
Jan 20, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$484k 30,000 shares
$16.13
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $6.67M 1,392,991 shares
Last Trade
Jan 19, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$480k 30,000 shares
$16.00
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $6.82M 1,422,991 shares
Last Trade
Jan 12, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$241k 15,000 shares
$16.04
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $6.89M 1,437,991 shares
Last Trade
Jan 11, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$119k 7,394 shares
$16.03
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $6.92M 1,445,385 shares
Last Trade
Jan 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$244k 15,186 shares
$16.07
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $7M 1,460,571 shares
Last Trade
Jan 07, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$160k 10,000 shares
$16.04
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $7.04M 1,470,571 shares
Last Trade
Nov 11, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.4k 150 shares
$16.00
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $7.04M 1,470,721 shares
Last Trade
Nov 10, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$145k 9,045 shares
$16.06
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $7.09M 1,479,766 shares
Last Trade
Nov 09, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$108k 6,752 shares
$16.04
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $7.12M 1,486,518 shares
Last Trade
Apr 13, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$109k 7,703 shares
$14.13
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $7.08M 1,478,815 shares
Last Trade
Sep 23, 2019 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$22.6M 1,293,637 shares
$17.50
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $887k 185,178 shares
Last Trade
Sep 19, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$522k 28,106 shares
$18.58
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $0 0 shares
Last Trade
Sep 19, 2019 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$593k 31,918 shares
$18.58
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $0 0 shares
Last Trade
Sep 19, 2019 Sale (In The Money)Reported as In The Money on SEC Form 4.
$196k 10,557 shares
$18.58
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $1.02M 213,284 shares
Last Trade
Sep 19, 2019 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$3.95M 212,568 shares
$18.58
$4.79
Exagen
Exagen XGN
10% owner
Holding Value $3.43k 716 shares
Last Trade
Sep 18, 2019 Sale
No data
No data
$4.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up